Microneedle patches for vaccination in developing countries.
暂无分享,去创建一个
[1] S. Nakagawa,et al. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease , 2014, Journal of Neuroimmunology.
[2] J. Stockman,et al. Dissolving polymer microneedle patches for influenza vaccination , 2012 .
[3] A. Crean,et al. Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice , 2011, PloS one.
[4] Mark R. Prausnitz,et al. Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine , 2012, PloS one.
[5] Mark R Prausnitz,et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. , 2014, Vaccine.
[6] Ying Zhang,et al. Development of Lidocaine-Coated Microneedle Product for Rapid, Safe, and Prolonged Local Analgesic Action , 2011, Pharmaceutical Research.
[7] Mark R Prausnitz,et al. Development of a thermostable microneedle patch for influenza vaccination. , 2015, Journal of pharmaceutical sciences.
[8] J. Hooper,et al. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge , 2006, Vaccine.
[9] N. Mickuvienė,et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial , 2009, BMC medicine.
[10] Frank O. Nestle,et al. Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.
[11] W. Jiskoot,et al. Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment , 2009, Pharmaceutical Research.
[12] M. Kermode. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. , 2004, Health promotion international.
[13] M. Prausnitz,et al. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[14] I. Frazer,et al. Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model , 2010, PloS one.
[15] I. Frazer,et al. Increasing mechanical stimulus induces migration of Langerhans cells and impairs the immune response to intracutaneously delivered antigen , 2011, Experimental dermatology.
[16] M. Prausnitz,et al. A microneedle patch containing measles vaccine is immunogenic in non-human primates. , 2015, Vaccine.
[17] P. Lydon,et al. Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade? , 2014, Bulletin of the World Health Organization.
[18] M. Sawhney,et al. Why children are not vaccinated: a review of the grey literature. , 2012, International health.
[19] P. van Damme,et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. , 2009, Vaccine.
[20] Y. Levin,et al. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same? , 2014, Vaccine.
[21] M. Kendall,et al. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. , 2010, Vaccine.
[22] M. Prausnitz,et al. Bacillus Calmette-Guérin vaccination using a microneedle patch. , 2011, Vaccine.
[23] I. Frazer,et al. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[24] Mark R. Prausnitz,et al. Stability of influenza vaccine coated onto microneedles. , 2012, Biomaterials.
[25] R. Fields,et al. Drivers of routine immunization coverage improvement in Africa: findings from district-level case studies , 2014, Health policy and planning.
[26] Mark R. Prausnitz,et al. Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization , 2010, Journal of Virology.
[27] Mark R. Prausnitz,et al. Local Response to Microneedle-Based Influenza Immunization in the Skin , 2012, mBio.
[28] J. Díez-Domingo,et al. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: a comparative effectiveness study using the Valencia health care information system. , 2014, Vaccine.
[29] R. Compans,et al. Host Responses in Human Skin After Conventional Intradermal Injection or Microneedle Administration of Virus‐Like‐Particle Influenza Vaccine , 2013, Advanced healthcare materials.
[30] James C. Birchall,et al. Microneedles in Clinical Practice–An Exploratory Study Into the Opinions of Healthcare Professionals and the Public , 2010, Pharmaceutical Research.
[31] M. Prausnitz,et al. Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. , 2015, Vaccine.
[32] S. Madhi,et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. , 2010, The New England journal of medicine.
[33] K. Ahmad. MSF tuberculosis report criticises DOTS strategy. , 2004, The Lancet. Infectious diseases.
[34] G. Ippolito,et al. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007 , 2009, BMC medicine.
[35] W. Jiskoot,et al. Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array , 2010, Pharmaceutical Research.
[36] Yuqin Qiu,et al. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays , 2013, Biomedical Microdevices.
[37] F. de Looze,et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. , 2008, The Journal of infectious diseases.
[38] N. Harvey,et al. Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines , 2007, Clinical and Vaccine Immunology.
[39] M. Prausnitz,et al. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[40] Leonard A. Smith,et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock , 2008, Journal of immune based therapies and vaccines.
[41] M. Prausnitz,et al. Measles vaccination using a microneedle patch. , 2013, Vaccine.
[42] Mark R Prausnitz,et al. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. , 2010, Vaccine.
[43] M. Prausnitz,et al. Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection , 2012, Scientific Reports.
[44] Shawn T. Brown,et al. ne size does not fit all : The impact of primary vaccine container size n vaccine distribution and delivery , 2015 .
[45] W. Jiskoot,et al. Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations , 2010, Pharmaceutical Research.
[46] M. Prausnitz,et al. Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin , 2009, PloS one.
[47] Cheryl H. Dean,et al. Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates , 2005, Human vaccines.
[48] C. Sudfeld,et al. Effectiveness of measles vaccination and vitamin A treatment , 2010, International journal of epidemiology.
[49] Ryan F. Donnelly,et al. Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet , 2014, Pharmaceutical Research.
[50] Dexiang Chen,et al. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[51] P. Drain,et al. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. , 2003, Bulletin of the World Health Organization.
[52] Vincent J. Sullivan,et al. Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine , 2006, Infection and Immunity.
[53] Hervé Bourhy,et al. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. , 2010, Vaccine.
[54] Thomas Hankemeier,et al. Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats , 2014, Pharmaceutical Research.
[55] T. John,et al. Efficacy of inactivated poliovirus vaccine in India. , 1983, Bulletin of the World Health Organization.
[56] I. Frazer,et al. Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model , 2010, PloS one.
[57] Koen van der Maaden,et al. Microneedle technologies for (trans)dermal drug and vaccine delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[58] Jung-Hwan Park,et al. Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.
[59] C. Goujon,et al. Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults , 2014, Human vaccines & immunotherapeutics.
[60] M. Miller,et al. The cost of unsafe injections. , 1999, Bulletin of the World Health Organization.
[61] P. Das. Revolutionary vaccine technology breaks the cold chain. , 2004, The Lancet. Infectious diseases.
[62] T. Denning,et al. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts , 2015, Vaccine.
[63] M. Prausnitz,et al. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. , 2013, Vaccine.
[64] Yang Yang,et al. Advanced Materials and Nanotechnology for Drug Delivery , 2014, Advanced materials.
[65] Corona M. Cassidy,et al. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[66] F. Geissmann,et al. Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays , 2013, Proceedings of the National Academy of Sciences.
[67] Angela K. Shen,et al. The future of routine immunization in the developing world: challenges and opportunities , 2014, Global Health: Science and Practice.
[68] Mathias Currat,et al. Impact of Selection and Demography on the Diffusion of Lactase Persistence , 2009, PloS one.
[69] K. Brehm,et al. Characterization of S3Pvac Anti-Cysticercosis Vaccine Components: Implications for the Development of an Anti-Cestodiasis Vaccine , 2010, PLoS ONE.
[70] Conor O'Mahony,et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[71] L. Babiuk,et al. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization , 2009, Proceedings of the National Academy of Sciences.
[72] Kyoung-Mi Park,et al. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. , 2010, Antiviral research.
[73] J. Matriano,et al. Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.
[74] Yohei Mukai,et al. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[75] M. Prausnitz,et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge , 2009, Proceedings of the National Academy of Sciences.
[76] Vincent J. Sullivan,et al. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. , 2005, The Journal of infectious diseases.
[77] Yuxiao Tang,et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. , 2011, Bulletin of the World Health Organization.
[78] G. Kang,et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial , 2014, The Lancet.
[79] S. Gorman,et al. Microneedle-mediated transdermal bacteriophage delivery , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[80] M. Prausnitz,et al. A protective role of murine langerin+ cells in immune responses to cutaneous vaccination with microneedle patches , 2014, Scientific Reports.
[81] M. Prausnitz,et al. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine , 2010, Gene Therapy.
[82] Zhixian Gao,et al. Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle. , 2013, Biological & pharmaceutical bulletin.
[83] Mark R Prausnitz,et al. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[84] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[85] M. Prausnitz,et al. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. , 2010, The Journal of infectious diseases.
[86] Ramon Kaneno,et al. Efficiency of colon cancer RNA-transfected DC vaccine is enhanced by previous treatment of tumor cells with low concentration of 5-fluorouracil , 2012 .
[87] F. Fenner. Smallpox and its eradication , 1988 .
[88] Diane E. Sutter,et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery , 2002, Nature Medicine.
[89] B. Bloom,et al. Drying a tuberculosis vaccine without freezing , 2007, Proceedings of the National Academy of Sciences.
[90] P. Dormitzer,et al. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. , 2013, Vaccine.
[91] Christophe Fraser,et al. New Strategies for the Elimination of Polio from India , 2006, Science.
[92] Seajin Oh,et al. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. , 2012, Journal of pharmaceutical sciences.
[93] F. Ansaldi,et al. Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system , 2012, Human vaccines & immunotherapeutics.
[94] Bruce Y. Lee,et al. An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. , 2015, Vaccine.
[95] R. Linkins,et al. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt. , 1995, Bulletin of the World Health Organization.
[96] M. Prausnitz,et al. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[97] Vincent J. Sullivan,et al. Protective Immunity in Mice Achieved with Dry Powder Formulation and Alternative Delivery of Plague F1-V Vaccine , 2009, Clinical and Vaccine Immunology.
[98] J. Bouwstra,et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[99] R. Pettis,et al. Microneedle delivery: clinical studies and emerging medical applications. , 2012, Therapeutic delivery.
[100] C. O’Mahony,et al. Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route , 2014, Scientific Reports.
[101] Mark R Prausnitz,et al. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[102] M. Prausnitz,et al. Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage , 2010, Pharmaceutical Research.
[103] M. Ameri,et al. Effect of irradiation on parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system to produce a sterile product--adhesive compatibility. , 2010, Journal of pharmaceutical sciences.
[104] Gordon Larsen,et al. Technologies that make administration of vaccines safer. , 2004, Vaccine.
[105] A. Vrdoljak. Review of recent literature on microneedle vaccine delivery technologies , 2013 .
[106] Michael S Roberts,et al. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. , 2010, Small.
[107] D. Zehrung,et al. Intradermal delivery for vaccine dose sparing: overview of current issues. , 2013, Vaccine.